Does USTEKINUMAB Cause Psoriasis? 4,955 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,955 reports of Psoriasis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 5.8% of all adverse event reports for USTEKINUMAB.
4,955
Reports of Psoriasis with USTEKINUMAB
5.8%
of all USTEKINUMAB reports
361
Deaths
954
Hospitalizations
How Dangerous Is Psoriasis From USTEKINUMAB?
Of the 4,955 reports, 361 (7.3%) resulted in death, 954 (19.3%) required hospitalization, and 310 (6.3%) were considered life-threatening.
Is Psoriasis Listed in the Official Label?
Yes, Psoriasis is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
Infusion related reaction (4,471)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
DUPILUMAB (1,907)
Which USTEKINUMAB Alternatives Have Lower Psoriasis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE